How to Get a Lot of Attention by Claiming to Cure Cancer
If you want to stand in a scientific spotlight, you have to have a great act. What act could be grander than curing cancer? Not just any cancer, but all cancer. Not at some vague future date, but next year! This is exactly what an Israeli development-stage biopharmaceutical company did. On January 28, 2019 the keep reading
Excess Toxicity? Radiation Dose Creep after Prostatectomy
What goes up may not come down. At least, that’s what a new trend in prostate radiation therapy might lead you to believe. The trend is radiation dose escalation. It is occurring in patients who have a radical prostatectomy but whose clinical factors are considered to be a high risk for recurrence. By clinical factors, keep reading
2018: A Year of Advancements in Prostate Health
The year's most important advances in prostate cancer and men's health, all in one place—read online or download as a FREE e-book! keep reading
4 Questions You Should Ask About ED Drugs and Prostate Cancer Risk
Every man over a certain age knows about “the little blue pill” or the major brands Viagra, Cialis and Levitra. These medications are part of a class of drugs called PDE5 inhibitors, which are the first effective oral products to treat erectile dysfunction (ED). ED is a problem that commonly occurs as men get older. keep reading
Prostatectomy is on the Decline for Low-risk Prostate Cancer
For decades, thousands of men with insignificant PCa have been overtreated with prostatectomies. A new study raises questions about the practice and sheds light on the prostatectomy's decline. keep reading
The Harsh Economics of Prostate Cancer
Over the years, I have written on various topics related to prostate health. The obvious ones include prostate cancer (PCa): how to detect, diagnose and treat it without wrecking quality of life and masculinity, nutrition, exercise, stress management, and even new drugs like metformin and rapamycin that were developed for other conditions but turn out keep readingHow to Increase the Odds for Successful Active Surveillance
Let’s start with a short quiz: What is the current preferred strategy to manage low-risk prostate cancer? a) Nerve-sparing robotic prostatectomy b) Focal treatment c) Active Surveillance d) Vitamin E, saw palmetto supplements, and avoid red meat If you answered “c) Active Surveillance,” you are correct. According to a 2017 joint guideline statement from four keep readingMore Than One Prostate Cancer in a Single Prostate?
Multifocal prostate cancer In the not-too-distant past, medical schools taught young urologists that all prostate cancer (PCa) is multifocal – scattered throughout the gland. The belief was, “If you find it in one place, it must also be in other places even if undetectably small.” As a result, they carried this belief into their clinical keep reading
The National Rollercoaster of Testosterone Use
“…once drugs are proven effective and approved for the specific population in which they are tested, they quickly end up getting prescribed to a wider body of patients than is likely needed or safe.” Health News Review Testosterone and aging If you’re a guy, the word hypogonadism is likely not a part of the words keep reading
